Sms Co., Ltd. TSE:2175

SMS : FY03-26 Q1 SMS Consolidated Financial Results

Published

Source: MarketScreener

DISCLAIMER: This document has been translated from a part of the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

July 29, 2025

Consolidated Financial Resultsfor the Three Months Ended June 30, 2025 (Under Japanese GAAP)

Company name: SMS CO., LTD. Listing: Tokyo Stock Exchange

Securities code: 2175

URL: https://www.bm-sms.co.jp/ Representative: Natsuki Goto, CEO Inquiries: Masato Sugizaki, CFO

Telephone: +81-3-6721-2400

Scheduled date to commence dividend payments: -

Preparation of supplementary material on financial results: Yes

Holding of financial results briefing: Yes for institutional investors and analysts

(Yen amounts are rounded down to millions, unless otherwise noted.)

  1. Consolidated financial results for the three months ended June 30, 2025 (from April 1, 2025 to June 30, 2025)
    1. Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.)

      Net sales

      Operating profit

      Ordinary profit

      Profit attributable to owners of parent

      Three months ended

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      Millions of yen

      %

      June 30, 2025

      18,672

      7.1

      3,616

      20.5

      4,785

      16.3

      3,940

      24.6

      June 30, 2024

      17,426

      14.7

      3,000

      (19.5)

      4,114

      (10.7)

      3,163

      (6.7)

      Note: Comprehensive income For the three months ended June 30, 2025:

      ¥2,535 million

      [(46.0)%]

      For the three months ended June 30, 2024:

      ¥4,693 million

      [33.8%]

      Basic earnings per share

      Diluted earnings per share

      Three months ended

      Yen

      Yen

      June 30, 2025

      47.17

      47.17

      June 30, 2024

      36.71

      36.70

    2. Consolidated financial position

    Total assets

    Net assets

    Equity-to-asset ratio

    As of

    Millions of yen

    Millions of yen

    %

    June 30, 2025

    72,328

    43,897

    60.4

    March 31, 2025

    76,540

    47,319

    61.5

    Reference: Equity

    As of June 30, 2025: ¥43,668 million

    As of March 31, 2025: ¥47,089 million

  2. Cash dividends

    Annual dividends per share

    First quarter-end

    Second quarter-end

    Third quarter-end

    Fiscal year-end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Fiscal year ended

    March 31, 2025

    -

    0.00

    -

    28.50

    28.50

    Fiscal year ending March 31, 2026

    -

    Fiscal year ending March 31, 2026 (Forecast)

    0.00

    -

    -

    -

    Note: Revisions to the forecast of cash dividends most recently announced: None

  3. Forecast of consolidated financial results for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026)

(Percentages indicate year-on-year changes.)

Net sales

Operating profit

Ordinary profit

Profit attributable to owners of parent

Basic earnings per share

Fiscal year ending March 31, 2026

Millions of

yen

%

Millions of

yen

%

Millions of

yen

%

Millions of

yen

%

Yen

67,544

10.8

7,287

15.0

9,468

13.3

7,029

16.1

84.14

Note: Revisions to the earnings forecasts most recently announced: None

* Notes
  1. Significant changes in the scope of consolidation during the period: None

  2. Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: Yes

  3. Changes in accounting policies, changes in accounting estimates, and restatement

    1. Changes in accounting policies due to revisions to accounting standards and other regulations: None

    2. Changes in accounting policies due to other reasons: None

    3. Changes in accounting estimates: None

    4. Restatement: None

  4. Number of issued shares (common shares)

    1. Total number of issued shares at the end of the period (including treasury shares)

      As of June 30, 2025

      87,561,600 shares

      As of March 31, 2025

      87,561,600 shares

    2. Number of treasury shares at the end of the period

      As of June 30, 2025

      5,162,351 shares

      As of March 31, 2025

      2,599,151 shares

    3. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Three months ended June 30, 2025

83,540,249 shares

Three months ended June 30, 2024

86,185,768 shares

  • Review of the Japanese-language originals of the attached consolidated quarterly financial statements by certified public accountants or an audit firm: None

  • Proper use of earnings forecasts, and other special matters (Cautions on forward-looking statements, etc.)

Forward-looking statements, such as earnings forecasts, contained in this material are based on information available as of the date of submission and certain assumptions that are judged to be reasonable, and actual results may differ from the forecasts due to various factors.

(Method of accessing supplementary material on financial results)

Supplementary financial results materials are disclosed on TDnet on the same day.

Table of Contents for Attached Materials

  1. Overview of Operating Results, etc 2

    1. Explanation of Operating Results 2

    2. Explanation of Financial Position 7

    3. Explanation of Consolidated Financial Results Forecast and Other Forward-looking Information 7

  2. Quarterly Consolidated Financial Statements and Primary Notes 8

    1. Consolidated Balance Sheets 8

    2. Consolidated Statements of Income (Cumulative) and Consolidated Statements of Comprehensive Income (Cumulative) 10

      Consolidated statements of income (cumulative) 10

      Consolidated statements of comprehensive income (cumulative) 11

    3. Notes to Quarterly Consolidated Financial Statements 12

(Going concern assumption) 12

(Special accounting methods for preparing quarterly consolidated financial statements) 12

(Significant changes in shareholders' equity) 12

(For quarterly consolidated balance sheets) 12

(For quarterly consolidated statements of income) 12

(For quarterly consolidated statements of cash flows) 12

(Segment information, etc.) 12

(Significant subsequent events) 13

  1. ‌Overview of Operating Results, etc.‌
    1. ‌Explanation of Operating Results‌

      (ⅰ) Consolidated operating results (cumulative)

      (Millions of yen)

      Three months ended June 30, 2024

      Three months ended June 30, 2025

      Change (amount)

      Change (percentage)

      Net sales

      17,426

      18,672

      1,245

      7.1%

      Operating profit

      3,000

      3,616

      615

      20.5%

      Ordinary profit

      4,114

      4,785

      670

      16.3%

      Profit attributable to

      owners of parent

      3,163

      3,940

      777

      24.6%

      The Group’s Mission is “to improve the quality of life by providing information infrastructure for an aging society.” We regard Medical Care, Elderly/Disability Care, Healthcare, and Senior Life as the business domains required in an aging society and define information infrastructure as a platform to connect those to whom we provide value: end users, professionals, and operators. By building information infrastructure that supports people in an aging society through information, we are working to solve various issues that arise in an aging society and contribute to improving the quality of life.

      An unprecedented era of low birth rate, aging and population decline

      Japan is entering an era of simultaneous rapid aging and population decline, the likes of which no one has ever experienced. As of January 2025, the number of elderly people aged 65 and over was 36.19 million.*1 The aging rate, already at 29%, is expected to reach approximately 35% by 2040 when the elderly population approaches its peak of over 39 million. On the other hand, the working-age population aged 15–64, who play a central role in economic activities, continues to drop, and its relative percentage of the population composition is projected to decline from 68% in 2000 to nearly 55% by 2040.*2

      Three critical issues faced by an aging society

      Against the backdrop of these demographic changes, the state of society, including economic trends, national policies, and people's values, has undergone significant changes, and new issues have emerged that did not exist before. The Group recognizes that there are three important social issues that we need to solve in an aging society.

      Issue 1: Difficulty in sustaining high-quality medical care and elderly/disability care services

      While the demand for medical care and elderly/disability care services is increasing as the population ages, the shortage of workers to support these services has become a serious problem due to a decline in the working-age population. According to national estimates, by 2040, an additional 320,000 nurses will be required compared to 2018, and an additional 570,000 care workers will be required compared to 2022.*3 The growing shortage of medical care and elderly/disability care professionals will make it difficult to sustain high-quality medical care and elderly/disability care services.

      Issue 2: More severe burden on the working generation

      As the elderly population increases, social security expenses that support pensions, medical care, elderly care, and other welfare services are expected to increase to 190 trillion yen in 2040, about 1.6 times the 2018 level.*4 On the other hand, due to the decline in the working-age population, we will see shrinking workforces, not only in medical care and elderly/disability care, but in all industries in Japan. The average number of people in the working generation required to support one elderly person is expected to decline from 2.1 in 2018 to 1.6 in 2040, placing an increasingly heavy burden on the working generation.*5

      Issue 3: Difficulty in solving problems related to living in an aging society

      As the population ages, the services required in society are also changing. In an aging society, new needs such as elderly care and end-of-life planning are emerging and the demand for these services is expanding. However, the available information related to living in an aging society is insufficient in terms of quality and quantity, and it is not provided in an organized manner. Furthermore, there are also concerns that the future labor shortage in many industries will result in an inability to adequately supply the services required by an aging society. This will make it difficult for the elderly and their families to solve various life-related problems.

      Issues in Japan's aging society and our solutions

      In order to solve the three issues facing Japan’s aging society through building information infrastructure, the Group has established specific solutions targeting each social issue.

      For Issue 1: difficulty in sustaining high-quality medical care and elderly/disability care services, in addition to solving the overwhelming supply-demand gap of medical care and elderly/disability care professionals, it is important to improve the operational efficiency and solve management issues of business operators that provide medical care and elderly/disability care services. Therefore, we believe that the solution is to "solve labor shortages and uneven distribution of medical care and elderly/disability care professionals" and to "improve the management of medical care and elderly/disability care operators."

      For Issue 2: more severe burden on the working generation, resulting from increasing social security costs and a decreasing working-age population, we will be able to solve this issue through "increasing the number of healthy people in the work force" by enabling more people to work productively in good health for a long period of time.

      For Issue 3: difficulty in solving problems about life in an aging society, our solution is to "provide a variety of options and high-quality decision-making information" by organizing various types of information related to Japan's aging society in an easy-to-understand manner.

      Initiatives in each business area

      Based on the above issues and their solutions, the Group is working to solve social issues in each business area, aiming to realize our Mission and increase our corporate value over the long term through sustainable growth.

      In the Career Business, we aim to solve the social issue 1: "difficulty in sustaining high-quality medical care and elderly/disability care services," by contributing to "solving labor shortages and uneven distribution of medical care and elderly/disability care professionals" through optimal matching between care professionals and care business operators.

      In the medical care field, it is expected that the medical functions required will shift from acute care to chronic and home care as demand expands. As the demand for medical care changes, the supply and demand gap for healthcare professionals is widening. In addition, "uneven distribution among medical care functions" and "uneven distribution among regions" are also becoming major issues. In our Medical Care Career business, we assist professionals in "taking their careers one step forward" throughout their professional lives by providing them with various types of support including support in finding/changing jobs, returning to work and developing their careers. We help operators solve their HR issues, such as recruitment and improvement of working environments. In addition, by appropriately communicating to professionals the appeal of the work styles and careers that they can realize at those operators, we can offer professionals job opportunities at better operators needed by society. We contribute to solving the shortage and uneven distribution of medical care professionals by promoting optimal matching to the medical functions and local operators in demand by society, while supporting professionals to pursue their ideal careers.

      In the elderly/disability care field, as the number of elderly people increases, the number of people requiring elderly care in their daily lives is expected to increase, and it is certain that the overwhelming shortage of professionals will continue long term. According to national estimates, an additional 250,000 care workers will be required in 2026 compared to 2022, and this number is expected to increase to 570,000 by 2040.*3 In our Elderly Care Career business, we are working to increase the number of new workers entering the elderly/disability care industry, while at the same time encouraging professionals to stay in the industry and reducing the number of people leaving the industry, which will lead to solving the overwhelming shortage of elderly/disability care professionals. We provide support for inexperienced people at our school to obtain certification and encourage people from outside the industry to start their careers in the elderly/disability care field by supporting them in getting jobs at operators that offer good working and training environments even for those with no experience. In addition, following employment, we provide a retention support service to help workers overcome their worries and concerns at the workplace, thereby preventing them from retiring from the industry early. In addition, we promote optimal matching between job seekers and elderly/disability care operators so that elderly care professionals can work with a sense of job satisfaction by making use of their skills and experience. We also contribute to encouraging professionals to stay in the industry and reducing the number of people leaving the industry by helping operators solve their HR issues, such as recruitment and improvement of working environments which will lead to realizing better working environments for them.

      We will continue to maximize the value we provide to professionals and operators and achieve sustainable growth over the long term, aiming to solving the shortage and uneven distribution of medical care and elderly/disability care professionals.

      In the Elderly/Disability Care Operators Business, we aim to solve the social issue 1: "difficulty in sustaining high-quality medical care and elderly/disability care services," by contributing to "improving the management of elderly/disability care operators" through

      the provision of Kaipoke, a subscription-based management support platform for elderly/disability care operators. There are approximately 260,000 elderly care offices*6 nationwide, more than 80% of which are corporations operating one or two offices*7, and many of them are facing management issues due to their small scale. In addition to a large amount of time spent on indirect work such as document preparation, there are business and management problems such as a labor shortage due to difficulty in hiring staff, low purchasing power, and cash-flow issues, making it difficult to fully focus on the care for the elderly, and this is a common concern among elderly care operators. In addition, the number of users of welfare services for persons with disabilities is increasing year by year due to the growing social awareness toward disabilities and easier access to diagnosis. Accordingly, the number of service offices providing welfare services for persons with disabilities has been continuously increasing, but they face the same management issues as elderly care operators. Kaipoke provides comprehensive support for the management of elderly/disability care operators, working to improve their management and service quality, with more than 40 services that support operations, recruitment, purchasing, finance, back office, M&A, etc., on top of the insurance claim service that is essential for elderly/disability care operations, through a one-stop platform.

      We will maximize the value provided by our management support platform through expanding our operator coverage to a wider range of elderly/disability care service types, increasing the number of customers, developing new services, promoting these services to our customers and analyzing/leveraging accumulated data on elderly/disability care operators, thereby achieving sustainable growth over the long term.

      In the New Business (Healthcare), we aim to solve the social issue 2: "more severe burden on the working generation," by contributing to "increasing the number of healthy people in the work force" through the provision of a platform that supports health and productivity management of companies. Due to a decline in the working-age population, Japan is expected to face a labor shortage in all industries in the future. Moreover, among the working generation, there are many patients/potential patients with lifestyle related diseases, which often progress to critical illnesses such as diabetes and dementia. Mental disorders caused by overworking or stress in the workplace are also serious, and the number of patients receiving medical treatment for depression and other mood disorders has been on the rise in recent years. In order to halt this decline in the work force and increase its productivity, it is essential for people to be able to work healthily for a long period of time. The Japanese government is focusing on measures to prevent lifestyle-related diseases and improve mental health. In particular, the government is actively promoting policies to promote the spread of "health and productivity management," in which companies work to improve the health of employees and their families. The Group will contribute to improving the health of their employees and their families by developing a health and productivity management platform, which provides companies and health insurance associations with evidence-based digital health services*8 that utilize the capabilities of healthcare professionals, such as doctors, nurses, and dietitians. Leveraging the Group’s strengths in healthcare professional networks, ICT capabilities, and proven results from verification projects conducted with ministries and national agencies, we offer effective solutions with a reasonable price, such as our Remote Specific Health Guidance Service for health insurance associations and our Remote Industrial Health Service for companies.

      We will maximize the value provided by the health and productivity management support platform through increasing the number of clients and users of our services, developing services necessary for health and productivity management, improving the quality of services through hiring/training healthcare professionals and analyzing/leveraging accumulated data, thereby achieving sustainable growth over the long term.

      In the New Business (Senior Life), we aim to solve the social issue 3: "difficulty in solving problems related to living in an aging society," by "providing a variety of options and high-quality decision-making information" through the development of a problem-solving platform that connects people with concerns and needs related to living to consultation services and services that help solve those concerns and needs. In our web community for people struggling with elderly care, we provide support in solving various problems centering on elderly care through interaction among members and advice from specialists. We also provide comprehensive support in solving all the problems faced by end users by connecting people who have clear needs relating to housing, food, end-of-life planning, etc. to services introducing business operators.

      We will maximize the value provided by the problem-solving platform through enhancing the value of a web community for people struggling with elderly care as a comprehensive consultation desk for elderly care, expanding the coverage of categories specific to an aging society / the range of services within each category, increasing the number of business partners that provide solutions to problems and helping business operators achieve better management, thereby achieving accelerated growth.

      In the Overseas Business (Medical Platform Business), we aim to solve the social issue: "low availability of medicines and medical devices, and inadequate quality of medical care in APAC," by "improving the availability and safety of medical care" through

      building a medical platform optimized for APAC that connects healthcare professionals and medical-related companies. We support the marketing activities of medical-related companies such as pharmaceutical companies around the world by utilizing the Group’s membership base of healthcare professionals in APAC. We contribute to supporting more effective and efficient marketing activities for medical-related companies by identifying, creating, organizing, and localizing valuable information and providing it to healthcare professionals, thereby expanding and enhancing the engagement of the membership bases of healthcare professionals.

      We will maximize the value provided by the medical platform through expanding the scope of our services to a broader range of industries/business types, increasing the number of clients, expanding the types of information provided to healthcare professionals and increasing its quality/quantity, expanding the membership bases of healthcare professionals, enhancing their engagement, and analyzing/leveraging accumulated data, thereby achieving sustainable growth over the long term.

      In the Overseas Business (Global Career Business), we aim to solve the social issue: "shortage and uneven distribution of healthcare professionals around the world" in the midst of increasing global needs for medical care services due to economic and population growth, by building an HCP (healthcare professional) supply platform that connects healthcare institutions and healthcare professionals around the world. We will contribute to improving the quality of medical care around the world by promoting optimal matching cross-borderly and domestically according to the supply and demand situation of healthcare professionals and healthcare institutions in each country.

      We will maximize the value provided by the HCP (healthcare professional) supply platform through expanding our operating countries, increasing the number of clients within these countries, increasing the number of countries / healthcare professionals we provide employment support, and increasing the volume of optimized matching between healthcare institutions and healthcare professionals, thereby achieving sustainable growth over the long term.

      The Group will contribute to solving social issues by capturing various business opportunities arising from the expanding market and creating a range of new services both domestically and internationally and achieve sustainable growth over the long term.

      The Group’s operating results for the three months ended June 30, 2025 , are as follows.

      Net sales amounted to 18,672 million yen (up 7.1% year-on-year) due to the expansion of the Career Business and the Kaipoke Business, etc.

      Operating profit amounted to 3,616 million yen (up 20.5% year-on-year), as we limited expense growth by factors such as the reduced hiring of career partners, in line with our initial plan.

      Ordinary profit amounted to 4,785 million yen (up 16.3% year-on-year).

      Profit attributable to owners of parent amounted to 3,940 million yen (up 24.6% year-on-year).

      *1. MIC, “Population estimates”

      1. National Institute of Population and Social Security Research “2023 Estimated future population of Japan”

      2. NursesMHLW, “Status of securing nurses and other nursing staff”

        Elderly care workers: MHLW, “Required number of elderly care staff based on the 9th plan for long-term care insurance”

      3. Cabinet Secretariat, CAO, MOF, MHLW, “Future outlook for social security in 2040” The amount is the total of pensions, medical care, and elderly care.

      4. MIC “Census”, “Population estimates”, National Institute of Population and Social Security Research “2023 Estimated future population of Japan”

      5. MHLW, "Statistics of Long-term Care Benefit Expenditures” (March 2024)

      6. MHLW, "Long-Term Care Information Publication System", "Information Provision System for residences with health and welfare services" Compiled based on information as of January 2025

      7. Digital Health: Improving the effects of medical care and healthcare by utilizing the latest digital health technologies such as AI, ICT, IoT, wearable devices, and big data analysis.

      (ⅱ) Overview by each business area

      The Group discloses four business areas: Career Business, Elderly/Disability Care Operators Business, Overseas Business, and New Business. The Career Business is further divided into Elderly Care Career and Medical Care Career.

      (Millions of yen)

      Business area

      Three months ended June 30, 2024

      Three months ended June 30, 2025

      Change (amount)

      Change (percentage)

      Career Business

      12,157

      13,069

      911

      7.5%

      Elderly Care Career

      5,526

      6,144

      618

      11.2%

      Medical Care Career

      6,630

      6,924

      293

      4.4%

      Elderly/Disability Care

      Operators Business

      2,824

      3,222

      397

      14.1%

      Overseas Business

      1,713

      1,535

      (177)

      (10.4%)

      New Business

      730

      844

      113

      15.6%

      Total

      17,426

      18,672

      1,245

      7.1%

      In the Career Business, both Elderly Care Career and Medical Care Career grew with strong demand for hiring professionals by medical/elderly care business operators. We implemented measures to raise awareness of our services for nurses (e.g. commercials, offline events) from April to May. While a slowdown in job seekers' motivation to change jobs continues in some occupations, the environment for attracting job seekers is improving due to eased competition.

      As a result, net sales in the Career Business for the three months ended June 30, 2025, amounted to 13,069 million yen (up 7.5% year-on-year).

      In the Elderly/Disability Care Operators Business, Kaipoke, a management support platform for elderly/disability care operators, grew steadily. In addition to the expansion in the number of memberships, the increased usage of optional add-ons (factoring, tablets, smartphones, etc.), the M&A matching business, and the recruiting agent service for persons with disabilities also contributed to growth.

      As a result, net sales in the Elderly/Disability Care Operators Business for the three months ended June 30, 2025, amounted to 3,222 million yen (up 14.1% year-on-year).

      In the Overseas Business, Medical Platform Business grew steadily while the impact of factors such as temporary reductions in marketing budgets by some customers continued.

      Sales of Global Career Business decreased YoY, mainly due to a high base of comparison from the first quarter of the fiscal year ended March 31, 2025, which saw a large number of healthcare professionals starting work on-site, and concerns over the Middle East situation affecting cross-border travel of healthcare professionals.

      As a result, net sales in the Overseas Business for the three months ended June 30, 2025, amounted to 1,535 million yen (down 10.4% year-on-year).

      In the New Business, development and improvement of new services progressed, centering on services such as remote health guidance service and industrial health service using ICT in the Healthcare Business, and information service on renovation operators and funeral agency introduction service in the Senior Life Business.

      As a result, net sales in the New Business for the three months ended June 30, 2025, amounted to 844 million yen (up 15.6% year-on-year).

    2. ‌Explanation of Financial Position‌

      Total assets as of June 30, 2025, amounted to 72,328 million yen (decreased by 4,211 million yen from the end of the previous fiscal year). This was mainly due to an increase in accounts receivable - other resulting from an increase in the number of operators using Kaipoke factoring service, offset by a decrease in cash and deposits caused by the repurchase of shares and a decrease in goodwill and trademark right, etc. resulting from fluctuations in foreign exchange rates.

      Total liabilities as of June 30, 2025, amounted to 28,431 million yen (decreased by 790 million yen from the end of the previous fiscal year). This was mainly due to a decrease in accounts payable - other, resulting from the optimization of funding costs as the transaction volume of Kaipoke's factoring service increased.

      Net assets as of June 30, 2025, amounted to 43,897 million yen (decreased by 3,421 million yen from the end of the previous fiscal year). This was mainly due to an increase in retained earnings attributable to the recording of quarterly net profit attributable to owners of parent, offset by a decrease in shareholders' equity due to the repurchase of shares and a decrease in foreign currency translation adjustment resulting from fluctuations in foreign exchange rates.

    3. ‌Explanation of Consolidated Financial Results Forecast and Other Forward-looking Information‌

      The consolidated financial results for the three months ended June 30, 2025 have been progressing in line with the consolidated financial results forecast for the fiscal year ending March 31, 2026, which was announced on April 28, 2025. This forecast remains unchanged at present.

  2. ‌Quarterly Consolidated Financial Statements and Primary Notes‌
    1. ‌Consolidated Balance Sheets‌

      (Millions of yen)

      As of March 31, 2025

      As of June 30, 2025

      Assets

      Current assets

      Cash and deposits

      16,175

      13,014

      Accounts receivable - trade

      8,887

      8,055

      Work in process

      89

      61

      Supplies

      28

      30

      Accounts receivable - other

      12,516

      13,957

      Prepaid expenses

      1,285

      1,432

      Other

      46

      511

      Allowance for doubtful accounts

      (366)

      (350)

      Total current assets

      38,664

      36,713

      Non-current assets

      Property, plant and equipment

      Buildings

      1,295

      1,355

      Accumulated depreciation

      (641)

      (655)

      Buildings, net

      654

      700

      Tools, furniture and fixtures

      1,193

      1,170

      Accumulated depreciation

      (978)

      (973)

      Tools, furniture and fixtures, net

      215

      197

      Machinery, equipment and vehicles

      13

      12

      Accumulated depreciation

      (12)

      (11)

      Machinery, equipment and vehicles, net

      0

      0

      Right-of-use assets

      872

      827

      Accumulated depreciation

      (554)

      (572)

      Right-of-use assets, net

      317

      254

      Total property, plant and equipment

      1,187

      1,153

      Intangible assets

      Goodwill

      9,701

      8,974

      Software

      7,028

      7,208

      Trademark right

      13,176

      12,455

      Customer-related assets

      935

      803

      Other

      0

      0

      Total intangible assets

      30,841

      29,441

      Investments and other assets

      Investment securities

      2,875

      2,032

      Deferred tax assets

      1,437

      1,462

      Leasehold and guarantee deposits

      1,533

      1,524

      Total investments and other assets

      5,846

      5,020

      Total non-current assets

      37,876

      35,615

      Total assets

      76,540

      72,328

      (Millions of yen)

      As of March 31, 2025

      As of June 30, 2025

      Liabilities

      Current liabilities

      Accounts payable - trade

      423

      331

      Short-term borrowings

      3,500

      3,400

      Current portion of long-term borrowings

      1,901

      1,901

      Accounts payable - other

      11,875

      11,023

      Accrued expenses

      861

      1,244

      Income taxes payable

      1,295

      1,124

      Accrued consumption taxes

      824

      1,126

      Contract liabilities

      1,483

      1,784

      Deposits received

      184

      300

      Provision for bonuses

      1,042

      522

      Lease liabilities

      128

      84

      Other

      469

      526

      Total current liabilities

      23,990

      23,370

      Non-current liabilities

      Long-term borrowings

      2,350

      2,350

      Retirement benefit liability

      236

      230

      Deferred tax liabilities

      2,467

      2,312

      Lease liabilities

      174

      165

      Other

      2

      2

      Total non-current liabilities

      5,231

      5,061

      Total liabilities

      29,221

      28,431

      Net assets

      Shareholders' equity

      Share capital

      2,551

      2,551

      Capital surplus

      262

      261

      Retained earnings

      43,430

      44,949

      Treasury shares

      (5,713)

      (9,247)

      Total shareholders' equity

      40,531

      38,515

      Accumulated other comprehensive income

      Valuation difference on available-for-sale securities

      229

      230

      Foreign currency translation adjustment

      6,328

      4,922

      Total accumulated other comprehensive income

      6,558

      5,152

      Share acquisition rights

      229

      229

      Total net assets

      47,319

      43,897

      Total liabilities and net assets

      76,540

      72,328

    2. ‌Consolidated Statements of Income (Cumulative) and Consolidated Statements of Comprehensive Income (Cumulative)‌‌Consolidated statements of income (cumulative)‌

      (Millions of yen)

      Three months ended June 30, 2024

      Three months ended June 30, 2025

      Net sales

      17,426

      18,672

      Cost of sales

      1,596

      1,736

      Gross profit

      15,830

      16,936

      Selling, general and administrative expenses

      * 12,829

      * 13,319

      Operating profit

      3,000

      3,616

      Non-operating income

      Share of profit of entities accounted for using equity method

      1,099

      1,231

      Foreign exchange gains

      21

      -

      Other

      17

      11

      Total non-operating income

      1,138

      1,243

      Non-operating expenses

      Foreign exchange losses

      -

      34

      Interest expenses

      20

      32

      Other

      4

      8

      Total non-operating expenses

      24

      75

      Ordinary profit

      4,114

      4,785

      Extraordinary income

      Gain on sale of non-current assets

      0

      0

      Total extraordinary income

      0

      0

      Extraordinary losses

      Loss on sale and retirement of non-current assets

      4

      -

      Loss on withdrawal from business

      30

      -

      Total extraordinary losses

      34

      -

      Profit before income taxes

      4,079

      4,785

      Income taxes

      916

      844

      Profit

      3,163

      3,940

      Profit attributable to owners of parent

      3,163

      3,940

      ‌Consolidated statements of comprehensive income (cumulative)‌

      (Millions of yen)

      Three months ended June 30, 2024

      Three months ended June 30, 2025

      Profit

      3,163

      3,940

      Other comprehensive income

      Foreign currency translation adjustment

      1,578

      (1,390)

      Share of other comprehensive income of entities accounted for using equity method

      (48)

      (15)

      Total other comprehensive income

      1,530

      (1,405)

      Comprehensive income

      4,693

      2,535

      Comprehensive income attributable to

      Comprehensive income attributable to owners of parent

      4,693

      2,535

      Comprehensive income attributable to non-controlling interests

      -

      -

    3. ‌Notes to Quarterly Consolidated Financial Statements‌

‌(Going concern assumption)‌

None to report

‌(Special accounting methods for preparing quarterly consolidated financial statements)‌

Tax expenses are calculated as follows, with the exception of certain consolidated subsidiaries:

The effective tax rate after the application of tax effect accounting is reasonably estimated for profit before income taxes for the consolidated fiscal year, including the three months ended June 30, 2025. Tax expenses are calculated by multiplying profit before income taxes by this estimated effective tax rate. Income taxes-deferred are included in income taxes.

‌(Significant changes in shareholders' equity)‌

None to report

‌(For quarterly consolidated balance sheets)‌

None to report

‌(For quarterly consolidated statements of income)‌

* Major items and amounts included in selling, general and administrative expenses are as follows:

(Millions of yen)

Three months ended

June 30, 2024

Three months ended

June 30, 2025

Salaries and allowance

4,581

4,658

Advertising expenses

3,101

3,620

Business consignment expenses

855

905

Amortization of goodwill

274

242

Depreciation

654

829

Legal welfare expenses

761

796

Rents

551

576

Provision for bonuses

412

438

Retirement benefit expenses

8

6

Provision of allowance for doubtful accounts

34

19

‌(For quarterly consolidated statements of cash flows)‌

Consolidated statements of cash flows have not been prepared for the three months ended June 30, 2025. Depreciation (including amortization related to intangible assets excluding goodwill) and amortization of goodwill for the three months ended June 30 are as follows:

(Millions of yen)

Three months ended

June 30, 2024

Three months ended

June 30, 2025

Depreciation

654

829

Amortization of goodwill

274

242

‌(Segment information, etc.) [Segment information]‌

The business of the Company and its consolidated subsidiaries is a single business that aims to build an information infrastructure for an aging society and ancillary operations. Therefore, there are no segments subject to disclosure, so the descriptions are omitted.

‌(Significant subsequent events)‌

The Company resolved to issue Share Acquisition Rights to its directors and employees at its Board of Directors' meeting held on July 7, 2025 and issued them on July 24, 2025.

SMS Co., Ltd. No. 21 Share Acquisition Rights

Date of Resolution

July 7, 2025

Number of Share Acquisition Rights (units)

2,370

Number of Treasury Share Acquisition Rights (units)

Class of shares underlying Share Acquisition Rights

Common stock

Number of shares underlying Share Acquisition Rights (shares)

(Note 1)

237,000

Amount to be paid upon the exercise of Share Acquisition Rights

(yen) (Note 2)

1,462.5

Exercise period of Share Acquisition Rights

From July 1, 2028 to June 30, 2033

Issue price and amount to be incorporated into stated capital for shares issued upon exercise of Share Acquisition Rights (yen)

(Note 3)

Issue price

Amount to be incorporated into stated capital

1,462.5

731.25

Conditions for exercising Share Acquisition Rights

(Note 4)

Matters on acquisition of Share Acquisition Rights through transfer

Acquiring the Share Acquisition Rights through transfer shall require approval through a resolution by the

Company’s Board of Directors.

Treatment of Share Acquisition Rights upon corporate

reorganization

(Note 5)

(Note 1) If the Company has, subsequent to the allotment date of the Share Acquisition Rights, conducted a stock split (including, hereinafter, gratis allotment of the Company’s common stock) or reverse stock split, the Number of Shares Granted shall be adjusted using the formula shown below; provided that such adjustment shall be made only for the number of shares underlying the unexercised Share Acquisition Rights at that point in time, and any fraction less than one share resulting from the adjustment shall be rounded down to the nearest whole number:

Adjusted Number of

Shares Granted

Number of Shares Granted

before adjustment

×

Split (or reverse split) ratio

(Note 2) If the Company has, subsequent to the allotment date of the Share Acquisition Rights, effected a stock split or reverse stock split, the Exercise Price shall be adjusted using the following formula, and any fraction less than one yen resulting from the adjustment shall be rounded up to the nearest yen:

Adjusted Exercise Price

Exercise Price before adjustment

×

1

Split (or reverse split) ratio

If the Company has, subsequent to the allotment date of the Share Acquisition Rights, issued new shares or disposed treasury shares at a price below the market value (meaning a price that is particularly low compared to a fair issue price) of the common stock of the Company (excluding the cases of the issuance of new shares or the disposal of treasury shares due to the exercise of the Share Acquisition Rights, and the transfer of treasury shares through share exchange), the Exercise Price shall be adjusted using the following formula. Any fraction less than one yen resulting from the adjustment shall be rounded up to the nearest yen:

Adjusted Exercise Price

Exercise Price before adjustment

Number of shares outstanding

Number of new shares issued ×

Amount to be paid in per share

×

Market price per share before issuance of new shares

Number of shares outstanding Number of new shares issued

(Note 3) The maximum amount of increase in capital stock and capital surplus per Share Acquisition Right shall be the sum of the amount to be paid at the time of exercise (1,462.5 yen per share, 100 shares underlying each Share Acquisition Right) and the book value per Share Acquisition Right at the time of exercise (47,200 yen per Share Acquisition Right). The amount to be incorporated into stated capital shall be one-half of the maximum amount of increase in capital stock and capital surplus calculated in accordance with Article 17, Paragraph 1 of the Ordinance on Accounting of Companies. Any fraction less than one yen resulting from the calculation shall be rounded up to the nearest yen.

(Note 4) Conditions for exercising Share Acquisition Rights

  1. If the amount of the adjusted operating income in the fiscal year ending March 2028 has exceeded each of the

    levels stated in (a) to (d) below, a share acquisition right holder may exercise the number of the Share Acquisition Rights equivalent to each predetermined rate of the Share Acquisition Rights allotted to each holder (the “Exercisable Rate”).

    1. When the adjusted operating income has exceeded 8,355 million yen, the Exercisable Rate shall be 20%

    2. When the adjusted operating income has exceeded 8,937 million yen, the Exercisable Rate shall be 50%

    3. When the adjusted operating income has exceeded 9,547 million yen, the Exercisable Rate shall be 70%

    4. When the adjusted operating income has exceeded 10,847 million yen, the Exercisable Rate shall be 100%

      In determining the values of the adjusted operating income above, the amount calculated below shall be used as a reference value. It is the amount obtained by adding stock-based compensation expenses in the notes to the consolidated financial statements in the Company’s annual securities report for the relevant fiscal year, to operating income of the consolidated statement of income in the said report. In case where any indicator used as a reference value should be changed or modified due to the change in the accounting standards and other reasons, the Company shall separately establish an applicable indicator as a reference value through a resolution at a Board of Directors’ meeting. In case where there is a fractional number of less than one in the exercisable Share Acquisition Rights, the number shall be truncated.

  2. A Share Acquisition Rights holder does not need to be a director or an employee of the Company at the time of exercise of the Share Acquisition Rights. Except when the Board of Directors of the Company separately approves, a Share Acquisition Rights holder may not exercise the Share Acquisition Rights in cases where the holder is removed from his/her position or receives disciplinary dismissal, or when there is a case that falls upon any of the items stipulated in the agreement on allotment of the Share Acquisition Rights that the exercise of the Share Acquisition Rights shall not be appropriate.

  3. Heirs of a share acquisition right holder may not exercise the Share Acquisition Rights.

  4. In the event that the exercise of Share Acquisition Rights causes the number of outstanding shares of the Company to exceed its total number of authorized shares, said Share Acquisition Rights may not be exercised.

  5. Share Acquisition Rights constituting less than one unit may not be exercised.

(Note 5) In the event that the Company has carried out a merger (limited to a case where the Company will be extinguished as a result of the merger), absorption-type company split, incorporation-type company split, share exchange, or share transfer (collectively, the “Corporate Reorganization”), Share Acquisition Rights of the company that falls under any of sub-items (a) to (e) in Article 236, Paragraph 1, Item 8 of the Companies Act (the “Surviving Company”) shall be delivered to a holder of the remaining Share Acquisition Rights on the date when the Corporate Reorganization comes into effect (the “Remaining Share Acquisition Rights”), in accordance with the terms and conditions set out below, provided, however, that the foregoing shall apply only to cases where the delivery of the Surviving Company’s Share Acquisition Rights, in accordance with the terms and conditions set out below, has been stipulated in the absorption-type merger agreement, consolidation-type merger agreement, absorption-type company split agreement, incorporation-type company split plan, share exchange agreement, or share transfer plan, and in that case the Remaining Share Acquisition Rights shall be extinguished and the Surviving Company shall issue new Share Acquisition Rights.

  1. Number of Share Acquisition Rights of the Surviving Company to be delivered

    Said number shall be the same as the number of the Share Acquisition Rights owned by each holder of the Share Acquisition Rights.

  2. Class of shares of the Surviving Company underlying Share Acquisition Rights Such shares shall be the Surviving Company’s common stock.

  3. Number of shares of the Surviving Company underlying Share Acquisition Rights

    The number shall be determined in accordance with (Note 1), taking into account the terms and conditions of the Corporate Reorganization, etc.

  4. Value of property to be contributed upon exercise of Share Acquisition Rights

    The value of property to be contributed upon exercise of each share acquisition right to be delivered shall be determined by multiplying the number of shares of the Surviving Company underlying the said Share Acquisition Rights to be calculated according to 3) of (Note 5) by the post-corporate reorganization Exercise Price obtained through the adjustment of the Exercise Price in accordance with (Note 2), taking into account the terms and conditions of the Corporate Reorganization, etc.

  5. Period during which Share Acquisition Rights may be exercised

    The period shall commence either on the first day of the Exercise Period of the Remaining Share Acquisition Rights stipulated in the table above or on the day on which the Corporate Reorganization comes into effect, whichever comes later, and shall end on the last day of the Exercise Period of the Remaining Share Acquisition Rights stipulated in the table above.

  6. Matters concerning increases in stated capital and legal capital surplus in the event of shares being issued upon exercise of Share Acquisition Rights

    These shall be determined in accordance with (a) and (b) below.

    1. In the event of shares being issued upon exercise of the Share Acquisition Rights, an increase in the amount of stated capital shall be one-half of the maximum amount of increase in capital, etc., calculated in accordance with Article 17, Paragraph 1 of the Ordinance on Accounting of Companies. Any fraction less than one yen resulting from the calculation shall be rounded up to the nearest yen.

    2. In the event of shares being issued upon exercise of the Share Acquisition Rights, an increase in the amount of legal capital surplus shall be the amount obtained by subtracting the increase in capital in the above (a)

      from the maximum amount of increase in capital, etc. stated in the above (a).

  7. Restriction on acquisition of Share Acquisition Rights through transfer

    Restriction on acquisition through transfer shall require approval through a resolution of the Board of Directors of the Surviving Company.

  8. Other conditions for exercising Share Acquisition Rights These shall be determined in accordance with (Note 4).

  9. Grounds and conditions for acquisition of Share Acquisition Rights These shall be determined in accordance with (a) and (b) below.

    1. In the event that the Company’s General Meeting of Shareholders has approved (or, that the Company’s Board of Directors has resolved to approve, due to no approval required from the General Meeting of Shareholders) a merger agreement under which the Company will be extinguished, a split agreement or plan under which the Company will be split, or a share exchange agreement or share transfer plan under which the Company will become a wholly-owned subsidiary, the Company may acquire the entire amount of the Share Acquisition Rights gratis on or after the date specified separately by its Board of Directors.

    2. In the event that a holder of the Share Acquisition Rights becomes unable to exercise his/her Share Acquisition Rights due to (Note 4), prior to his/her exercising the right for the Share Acquisition Rights, the Company may acquire such Share Acquisition Rights gratis.

  10. Other terms and conditions shall be determined in accordance with the terms and conditions applied in the Surviving Company.